30 de junho de 2008

 

Hope and Pride Among Reasons for HIV Trial Participation

HIV patients taking part in an international phase III randomized trial overwhelmingly hoped for a personal benefit, but a majority also saw themselves as helping society and science.

Read more:

http://www.medpagetoday.com/PublicHealthPolicy/ClinicalTrials/tb/9904

28 de junho de 2008

 

Oncology drugs dominating the clinic

Oncology drugs are dominating the clinic, with studies on new anti-cancer compounds representing the largest percentage of new clinical trials initiated in 2007.

Read more:

http://www.outsourcing-pharma.com//news/ng.asp?n=86146&c=8oq2Xnjd4T8MH4jDp4AJwQ%3D%3D

17 de junho de 2008

 

Index Ranks Pharmaceutical Groups According to Third World Outreach

Read more


http://www.nytimes.com/2008/06/17/health/17glob.html?_r=1&scp=1&sq=Index+Ranks+Pharmaceutical+Groups+According+to+Third+World+Outreach+&st=nyt&oref=slogin


http://atmindex.org/

16 de junho de 2008

 

Sistemas de Regulación Ética de la Investigación Biomédica de Latinoamérica y Europa

EULABOR (por Sistemas de Regulación Ética de la Investigación Biomédica de Latinoamérica y Europa: Análisis comparativo de su Pertinencia y Aplicación para la Protección de Seres Humanos) es la primera red en este dominio entre Europa y Latinoamérica.


http://www.eulabor.org/

10 de junho de 2008

 

Anvisa- regulamento técnico para células-tronco

Células tronco - regulamentação técnica

Leia mais sobre o edital

http://www4.anvisa.gov.br/base/visadoc/CP/CP%5B15587-1-0%5D.PDF

2 de junho de 2008

 

Progress on AIDS, but Not Enough, U.N. Says

Nearly a million people began life-prolonging drug treatment in developing countries last year, but new infections far outstrip efforts to treat the sick.

Read more

http://www.nytimes.com/2008/06/03/world/africa/03aids.html?ref=health

This page is powered by Blogger. Isn't yours?

Assinar Postagens [Atom]